GlassScriptPhysician profile
Mark D Drummond
NPI 1356462972
$3,285.26
in general payments reported to CMS, 2019-2025
41 companies · $618 in 2025
The $618 reported for 2025 was more than what 76% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $715 · 2022: $324 · 2023: $855 · 2024: $773 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,246.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,186.62 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $270.36 | 2025 | Clottriever Bold Catheter, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $238.80 | 2021-2023 | Confirm Rx |
| Abbvie INC. | $169.08 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $132.83 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2024 | Airsupra |
| E.R. Squibb & Sons, L.L.C. | $121.82 | 2025 | Cobenfy |
| Amarin Pharma, INC. | $81.65 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $74.64 | 2021-2022 | |
| Glaxosmithkline, LLC. | $65.52 | 2023-2024 | Trelegy Ellipta |
| Pfizer INC. | $63.54 | 2021-2022 | |
| Edwards Lifesciences Corporation | $50.73 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Dexcom, INC. | $47.61 | 2023-2024 | Dexcom G6 Transmitter |
| Biogen, INC. | $45.20 | 2021 | |
| Novo Nordisk INC | $40.28 | 2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Drummond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.